On Tuesday, Denali Therapeutics Inc (NASDAQ: DNLI) was -0.30% drop from the session before settling in for the closing price of $23.29. A 52-week range
Denali Therapeutics Inc (NASDAQ: DNLI) on Friday, soared 6.73% from the previous trading day, before settling in for the closing price of $23.32. Within the
Denali Therapeutics Inc (NASDAQ: DNLI) kicked off on Tuesday, down -6.79% from the previous trading day, before settling in for the closing price of $25.63.
On Tuesday, Denali Therapeutics Inc (NASDAQ: DNLI) was 0.73% up from the session before settling in for the closing price of $24.50. A 52-week range
Denali Therapeutics Inc (NASDAQ: DNLI) flaunted slowness of -0.82% at $24.22, before settling in for the price of $24.42 at the close. Taking a more
Denali Therapeutics Inc (NASDAQ: DNLI) on Friday, plunged -11.95% from the previous trading day, before settling in for the closing price of $28.45. Within the
Denali Therapeutics Inc (NASDAQ: DNLI) flaunted slowness of -0.87% at $29.63, before settling in for the price of $29.89 at the close. Taking a more
On Friday, Denali Therapeutics Inc (NASDAQ: DNLI) was 5.91% up from the session before settling in for the closing price of $29.60. A 52-week range
Denali Therapeutics Inc (NASDAQ: DNLI) established initial surge of 6.87% at $29.55, before settling in for the price of $27.65 at the close. Taking a
Denali Therapeutics Inc (NASDAQ: DNLI) open the trading on Thursday, with a bit cautious approach as it glided -3.31% to $25.96, before settling in for
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
